Table 1 |
|||||
|
Percentage rizatriptan of prescribed and sold triptans before (May – July 2004) and after (May – July 2005) the intervention and absolute change in percentage rizatriptan (after minus before). |
|||||
|
Percentage rizatriptan before the intervention |
Percentage rizatriptan after the intervention |
Absolute change |
Relative change |
P-value |
|
|
|
|||||
|
Control |
6 (2 – 13) |
7 (2 – 11) |
0 (-7 - 5) |
-29 (-69 – 83) |
- |
|
Attachment I |
3 (1 – 10) |
8 (3 – 14) |
3 (-2 – 8) |
42 (-51 – 222) |
0.071 |
|
Attachment II |
7 (1 – 13) |
8 (2 – 17) |
1 (-4 – 6) |
-1 (-59 – 70) |
0.052 |
|
Attachment I + II |
5 (1 – 12) |
8 (3 – 16) |
2 (-3 – 7) |
20 (-54 – 140) |
0.031 |
|
|
|||||
|
Mantel's test was used for comparison of absolute change vs control. Values are presented as median percentage (25th – 75th percentile). |
|||||
|
Edward et al. BMC Clinical Pharmacology 2007 7:12 doi:10.1186/1472-6904-7-12 |
|||||
